Oncology Devices Market Growth Opportunities, Size, Share Analysis, Recent Developments And Forecast To 2033

The Business Research Company recently released a comprehensive report on the Global Oncology Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=3373&type=smp

According to The Business Research Company's, The oncology devices market size has grown rapidly in recent years. It will grow from $128.46 billion in 2023 to $153.93 billion in 2024 at a compound annual growth rate (CAGR) of 19.8%. The growth in the historic period can be attributed to rising prevalence of cancer, growing aging population, increasing demand for personalized cancer treatments, genomic profiling.

The oncology devices market size is expected to see rapid growth in the next few years. It will grow to $298.31 billion in 2028 at a compound annual growth rate (CAGR) of 18.0%. The growth in the forecast period can be attributed to minimally invasive surgical techniques, biodegradable implants, global expansion of healthcare, value-based care models, digital health integration. Major trends in the forecast period include advancements in radiation therapy, early detection technologies, advancements in oncology devices, liquid biopsies, ai-powered decision support.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Market Drivers and Trends:

A growing number of cancer cases across the globe is anticipated to boost the demand for the oncology devices market. Cancer is a major health problem across the globe and is the second leading cause of death in the USA. The increasing incidence of cancer is contributing to the surge in demand for oncology devices to treat cancer patients. The four most common types of cancer globally are prostate, lung, bowel, and female breast cancer, accounting for 43% of all new cancer cases. According to the American Cancer Society, there were 1.9 million new cases and 608,570 cancer deaths in 2021 in the USA. Therefore, the rise in cancer incidence is anticipated to boost the demand for the oncology drugs market.

Major companies operating in the oncology devices market are focusing on innovative products such as benchmark ultra plus system to drive revenues in their market. The benchmark ultra plus system is a fully automated and integrated platform used in pathology and diagnostic laboratories for various laboratory processes, including the preparation, staining, and imaging of tissue samples and slides. For instance, in June 2022, F. Hoffmann-La Roche AG, a Switzerland-based healthcare company that manufactures oncology devices launched the benchmark ultra plus system. This system comes with a number of advances, including updated software that is more user-friendly, remote monitoring capabilities, an integrated touchscreen for an improved user experience, and a more environmentally friendly waste system and product packaging. It can deliver high-quality, urgent results to physicians and patients because of its optimized workflow, testing effectiveness, and environmentally friendly features .

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:

Eckert & Ziegler BEBIG GmbH, Oncura Inc., GE Healthcare, Medtronic plc, Varian Medical Systems Inc., Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer, RaySearch Laboratories, Mevion Medical Systems, Vision RT, IsoRay, RefleXion Medical, Alpha Tau Medical, Nanobiotix, Mirada Medical Ltd., Navidea Biopharmaceuticals Inc.

Oncology Devices Market 2024 Key Insights:

• The oncology devices market size is expected to see rapid growth in the next few years. It will grow to $298.31 billion in 2028 at a compound annual growth rate (CAGR) of 18.0%.
• Rising Global Cancer Cases Drive Demand For Oncology Devices And Drugs
• Increasing Focus On Product Innovations To Provide Reliable Services To Their Customers
• North America was the largest region in the oncology devices market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=3373&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (https://www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.